Annual General Meeting Details

  • Meeting Date: Friday, 19th June, 2026 at 11:30 A.M. (IST)
  • Venue: Registered Office at Neville House, J. N. Heredia Marg, Ballard Estate, Mumbai - 400001
  • Record Date: Friday, 12th June, 2026 for dividend entitlement
  • Business to be transacted:

1. Adoption of Audited Financial Statements for FY ended 31st March, 2026

2. Declaration of Dividend of ₹87 per equity share of face value ₹10 each

3. Re-appointment of Mr. Jairaj Champaklal Bham (DIN: 02806038) as Director retiring by rotation

Dividend Information

  • Dividend per share: ₹87 on equity shares of ₹10 each
  • Total dividend amount: ₹174.00 lakhs (subject to shareholder approval)
  • Payment: To members on register as of 12th June, 2026
  • Tax implications: Dividend income taxable in hands of shareholders with TDS at prescribed rates

Financial Performance Summary (₹ in Lakhs)

| Particulars | FY 2025-26 | FY 2024-25 |

| Profit/(Loss) before tax | (9.85) | 3.73 |

| Tax expense | 1.02 | - |

| Profit/(Loss) after tax | (10.87) | 3.73 |

| Other Comprehensive Income (net of tax) | 160.52 | - |

| Total Comprehensive Income | 149.65 | 3.73 |

| Revenue from operations | - | 12.00 |

| Basic EPS (₹) | (5.44) | 1.87 |

Key Financial Position (as at 31st March, 2026)

  • Equity share capital: ₹20.00 lakhs (2,00,000 shares of ₹10 each)
  • Other equity: ₹191.38 lakhs
  • Total assets: ₹212.16 lakhs
  • Cash and cash equivalents: ₹202.95 lakhs
  • Investment property: ₹0.62 lakhs (net block)
  • Trade receivables: ₹2.16 lakhs
  • Current liabilities: ₹0.75 lakhs

Significant Transactions

  • Sale of investments: Sold 48,000 equity shares of INOR Medical Products Limited at ₹371.91 per share for aggregate consideration of ₹178.52 lakhs on 25th February, 2026
  • Accounting treatment: Entire gain of ₹178.52 lakhs recognized in Other Comprehensive Income as investment was designated as FVTOCI
  • Transfer to retained earnings: ₹160.45 lakhs transferred from OCI to retained earnings

Directors and Key Managerial Personnel

Directors as on 31st March, 2026:

  • Mr. Jairaj C. Bham (DIN: 02806038) - Non-Executive, Non-Independent Director
  • Mr. Sanjive Arora (DIN: 07852459) - Non-Executive, Independent Director
  • Mr. Nitin H. Datanwala (DIN: 00047544) - Non-Executive, Independent Director
  • Mrs. Bakhtavar A. Pardiwalla (DIN: 06721889) - Non-Executive, Non-Independent Woman Director

Changes during the year:

  • Mr. S. Raja resigned as Director w.e.f. 17th June, 2025
  • Ms. Mahak Saraf ceased as Company Secretary & CFO on 30th January, 2026
  • Ms. Bhumika Ojha appointed as Company Secretary & CFO w.e.f. 2nd February, 2026
  • Mr. Yash Goswami appointed as Manager w.e.f. 9th June, 2025 (approved by shareholders on 29th September, 2025)

Corporate Governance

  • Board meetings: 8 meetings held during the year
  • Board evaluation: Annual performance evaluation conducted for Board, its committees and individual directors
  • Committee composition:
  • Audit Committee: Mr. Sanjive Arora (Chairman), Mr. N.H. Datanwala, Mr. J.C. Bham
  • Nomination and Remuneration Committee: Mr. Sanjive Arora (Chairman), Mr. N.H. Datanwala, Mr. J.C. Bham
  • Independent Directors meeting: Held once on 12th February, 2026

Shareholding Pattern (as on 31st March, 2026)

Major shareholders (>5%):

  • Nowrosjee Wadia and Sons Limited: 86,943 shares (43.47%)
  • Goodeed Charitable Foundation: 38,950 shares (19.48%)
  • Ness Nusli Wadia: 13,800 shares (6.90%)

Promoter shareholding: 145,293 shares (72.65%)

Other Material Information

  • Related party transactions: All transactions at arm's length basis
  • Loans/guarantees/investments: No outstanding loans, guarantees or investments under Section 186
  • Deposits: No deposits accepted from public
  • Material orders: No significant orders from regulators/courts
  • Internal financial controls: Adequate and operating effectively
  • Vigil mechanism: Whistle Blower Policy in place
  • CSR: Not applicable to the company

E-voting Arrangements

  • Remote e-voting period: 16th June, 2026 (9:00 am) to 18th June, 2026 (5:00 pm)
  • Scrutinizer: Mr. Vaibhav Shah, Practicing Company Secretary
  • RTA: KFin Technologies Limited

#Tags: #TechnojetConsultants #AGM2026 #Dividend #SEBIDisclosure #RegulatoryCompliance #FinancialResults #Negative